Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2006-03-14
2006-03-14
Wilson, Michael C. (Department: 1632)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C435S325000
Reexamination Certificate
active
07011827
ABSTRACT:
Methods of treating individuals suspected of suffering from diseases, conditions or disorders of the Central Nervous System including nerve damage are provided wherein stable, homogeneous post-mitotic human neurons are into the individual's brain or at or near a site of nerve damage. Pharmaceutical compositions of stable, homogeneous post-mitotic human neurons and a pharmaceutically acceptable medium are also disclosed. Methods of generating non-human animal models of human CNS diseases, conditions or disorders by implanting stable, homogeneous post-mitotic human neurons into the brain of a non-human animal are disclosed. Non-human animals eith stable, homogeneous post-mitotic human neurons implanted in their brain are also disclosed.
REFERENCES:
patent: 5175103 (1992-12-01), Lee et al.
patent: 5792900 (1998-08-01), Lee et al.
patent: 6214334 (2001-04-01), Lee et al.
Redmond D.E. The Neuroscientist. 8:457-488, 2002.
Kleppner et al. The Journal of Comparative Neurology 357:618-632, 1995.
Spencer DD et al. New Eng J Med 327:1541-1548, 1992.
Andrews P.W., “Pluriopotent Embryonal Carcinoma Clones Derived from the Human Teratocarcinoma Cell Line Tera-2,”Lab Invest.1984 50:147-162.
Andrews P.W., “Retinoic Acid Induces Neuronal Differentiation of a Cloned Human Embryonal Caarcinoma Cell Line in Vitro,”Devel. Biol.1987 103:285-293.
Abraham et al., “Increased PKA and PKC Activities Accompany Neuronal Differentiation of NT2/D1 Cells”,J. Neuronsci, Res.1991 28:29-39.
Andrews et al., “The expressionof MHC antigens by human teratocarcinoma derived cell lines”,Tissue Antigens1981 17:493-500.
Backlund et. al., “Transplantation of adrenal nedullary tissue to striatum in parkinsonism”,J. Neurosurg.1985 62:169-173.
Cattaneo, E. et al., “Identifying and manipulating neuronal stem cells”,TINS1991 14:338-340.
Freed, C.A. et al., “Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months After Transplantation for Parkinson's Disease”,New Engl. J. Med.1992 327:1549-1555.
Fung K.-F. et al., “A Novel Modification of the Avidin-Biotin Complex Method for Immunohistochemical Studies of Transgenic Mice with Murine Monoclonal Antibodies”,J. Histochem. Cytochem.1992 40:1319-1328.
Kleppner et al., “Long-Term Survival and Maturation of Neurons Derived From the Human Cell Line N-tera 2 After Transplantation into Nude Mouse Brain”,Neuronsci. Abst.1992 18:782.
Lee et al., “Differentiation of NTERA-2 Clonal Human Embryonal Carcinoma Cells into Neurons Involves hte Induction of all Three Neurofilament Proteins,”J. Neuronsci.1986 6:514-521.
Lindvall et al., “Transplantation in Parkinson's Disease: Two Cases of Adrenal Medullary Grafts to the Putamen”,Ann. Neuronl.1987 22:457-468.
Madrazo et al., “Open Microsurgical Augograft of Adrenal Medulla to the Right Caudate Nucleus in Two Patients with Intractable Parkinson's Disease”,New Engl. J. Med.1987 316:831-834.
Pleasure and Lee, “NTera 2 Cells: A Human Cell Line Which Displays Characteristics Expected of a Human Committed Neuronal Progenitor Cell”,J. Neuronsci. Res.1993 35:585-602.
Pleasure et al., “Pure, Postmitotic, Polarized Human Neurons Derived from NTera 2 Cells Provide a System for Expressing Exogenous Proteins in Terminally Differentiated Neurons”,J. Neuronsci. Res.1992 12:1802-1815.
Poltorak et al., “Human Cortical Neuronal Cell Line (HCN-1): Further In Vitro Characterization and Suitability for Brain Transplantation”,Cell Transplant1992 I:3-15.
Renfranz et al., “Region-Specific Differentiation of the Hippocampal Stem Cell Line HiB5 upon Implantation into the Developing Mammalian Brain”,Cell1991 66:713-729.
Snyder et al., “Multipotent Neural Cell Lines Can Engraft and Participate in Development of Mouse Cerebellum”,Cell1992 68:33-51.
Spencer et al., “Unilateral Transplantation of Human Fetal Mesencephalic Tissue Into the Caudate Nucleus of Patients with Parkinson's Disease”,New Engl. J. Med.1992 327:1541-1548.
Trojanowski et al., “Medulloblastomas and Related Primitive Neuroectodermal Brain Tumors of Childhood Recapitulate Molecular Milestones in the Maturation of Neuroblasts”,Molec. Chem Neuropathol.1992 17:121-135.
Wiestler et al., “Retrovirus-Mediated Oncogene Transfer into Neural Transplants”,Brain Pathol.1992 2:47-59.
Widner et al., “Bilateral Fetal Mesencephalic Grating in Two Patients with Parkinsonism induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP),”New Engl. J. Med.1992 327:1541-1563.
Younkin et al., “Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line”,Proc. Natl. Acad. Sci. U.S.A.1993 90:2174-2178.
Pellegrino et al., “A Stereotaxic Atlas of the Rat Brain”,Plenum Press, New York1979.
Kondziolka et al., “Transplantation of cultured human neuronal cells in patients with stroke”, Neurology 2000 55:565-569.
Meltzer et al., “Serial [18F] Fluorodeoxyglucose Position Emission Tomography after Human Neuronal Implantation for Stroke”, Neurosurgery 2001 49:586-592.
Lee Virginia M.-Y.
Trojanowski John Q.
Licata & Tyrrell P.C.
Trustees of the University of Pennsylvania
Wilson Michael C.
LandOfFree
Compositions and methods for producing and using homogenous... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for producing and using homogenous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for producing and using homogenous... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3590616